Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma

Blood (2024) 144 (4): 359–367.

https://doi.org/10.1182/blood.2024024371

Published: 2024

Includes: Supplemental data

Journal Articles

Multiple Myeloma Patient Perceptions of Minimal Residual Disease Testing

Jay R. Hydren, Felipe Flores Quiroz, Patricia Alejandra Flores Pérez, Jorge Arturo Arturo Hurtado Martinez, Karla Mariana Castro Bórquez, Andrea Jimena Cuevas Vicencio, Andrea Isabel Robles Espinoza, Marilú Nájera Flores, Eduardo Franco Hernandez, Ana M. Sahagun Sanchez Aldana, Jennifer M. Ahlstrom

Blood (2023) 142 (Supplement 1): 2410.

https://doi.org/10.1182/blood-2023-190364

Published: 2023

Journal Articles

Age-Based Comparison of Stem Cell Transplantation during the First Line of Therapy for Multiple Myeloma Patients

Jorge Arturo Arturo Hurtado Martinez, Jay R. Hydren, Patricia Alejandra Flores Pérez, Mason S. Barnes, Felipe Flores Quiroz, Nathan Sweeney, Karla Mariana Castro Bórquez, Andrea Isabel Robles Espinoza, Jennifer M. Ahlstrom

Blood (2023) 142 (Supplement 1): 3598.

https://doi.org/10.1182/blood-2023-189796

Published: 2023

Journal Articles

Dietary Patterns Among Individuals with Plasma Cell Disorders Compared to the General US Population

Kadiatou Traore, Alankrita Taneja, Elan Gorshein, Francesca Castro, Andriy Derkach, Jorge Arturo Hurtado Martinez, Edith Serrano, Alexander Lesokhin, Jennifer M. Ahlstrom, Torin Block, Jay R. Hydren, Saad Z Usmani, Urvi A Shah

Blood (2023) 142 (Supplement 1): 7363.

https://doi.org/10.1182/blood-2023-186913

Published: 2023

Journal Articles

Age-Based Comparison of Dara-Rvd, Krd and Rvd Induction Therapies during the First Line of Therapy for Multiple Myeloma Patients

Jennifer M. Ahlstrom, Patricia Alejandra Flores Pérez, Felipe Flores Quiroz, Karla Mariana Castro Bórquez, Mason S. Barnes, Jay R. Hydren, Jorge Arturo Arturo Hurtado Martinez

Blood (2023) 142 (Supplement 1): 6703.

https://doi.org/10.1182/blood-2023-190483

Published: 2023

Journal Articles

Unraveling the Dynamics of Protein Secretion in Multiple Myeloma: A Comparative Study of Non-Secretory Patterns and Disease Evolution

Jorge Arturo Arturo Hurtado Martinez, Patricia Alejandra Flores Pérez, Felipe Flores Quiroz, Karla Mariana Castro Bórquez, Nathan Sweeney, Christian Cheung, Andrea Isabel Robles Espinoza, Andrea Jimena Cuevas Vicencio, Eduardo Franco Hernandez, Marilú Nájera Flores, Ana M. Sahagun Sanchez Aldana, Jennifer M. Ahlstrom, Jay R. Hydren

Blood (2023) 142 (Supplement 1): 6704.

https://doi.org/10.1182/blood-2023-190557

Published: 2023

Journal Articles

The Relationship between Therapeutic Pressure and Multiple Myeloma Risk Stratification: A 5 Year Real-World-Data Analysis

Jay R. Hydren, Jorge Arturo Hurtado Hurtado Martinez, Ana Sahagun, Christian S. Cheung, Eduardo Franco Hernandez, Patricia Alejandra Flores Pérez, Felipe Flores Quiroz, Marilú Nájera Flores, Andrea Isabel Robles Espinoza, Andrea Jimena Cuevas Vicencio, Thomas H. Molina, Jennifer M. Ahlstrom, Nathan W. Sweeney

Blood (2022) 140 (Supplement 1): 12583–12584.

https://doi.org/10.1182/blood-2022-170388

Published: 2022

Journal Articles

Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study

Sikander Ailawadhi, Jay R. Hydren, Leyla Bojanini, Nathan W. Sweeney, Felicia Seng, Mizba Baksh, Ahsan Rasheed, Mays Abdulazeez, Meghna Ailawadhi, Keren George, Ricardo D Parrondo, Vivek Roy, Victoria R. Alegria, Pooja Advani, Rami Manochakian, Jason S. Starr, Taimur Sher, Jennifer M. Ahlstrom, Asher Chanan-Khan

Blood (2022) 140 (Supplement 1): 7941–7942.

https://doi.org/10.1182/blood-2022-167005

Published: 2022

Journal Articles

Microbial Changes in Response to a Plant-Based Diet and/or Supplements in SMM Patients: A National Multi-Arm Randomized Prospective Telehealth Study Via Healthtree: The Nutrition Prevention (NUTRIVENTION-2) Study

Francesca Castro, Nathan W. Sweeney, Andriy Derkach, Kadiatou Traore, Aishwarya Anuraj, Laura Guttentag, Jenna Blaslov, Ana Sahagun, Jay Hydren, Cynthia Chmielewski, Terry Golombick, Justin R Cross, Jun J Mao, Marcel R M van den Brink, Saad Usmani, Jennifer M. Ahlstrom, Alexander M Lesokhin, Urvi A Shah

Blood (2022) 140 (Supplement 1): 13079–13081.

https://doi.org/10.1182/blood-2022-160241

Published: 2022

Journal Articles

Physical Activity in Patients with Monoclonal Gammopathies - a Healthtree Cure Hub Study

Jens Hillengass, Michaela Hillengass, Nathan W. Sweeney, Thomas H. Molina, Jennifer M. Ahlstrom, Rikki Cannioto, Kirsten Moysich, Janine M. Joseph

Blood (2022) 140 (Supplement 1): 7136–7137.

https://doi.org/10.1182/blood-2022-162327

Published: 2022

Journal Articles

The Top Concerns at and Since Diagnosis: Standard v. High Risk Myeloma Patients

Jorge Arturo Hurtado Hurtado Martinez, Nathan W. Sweeney, David F. Barton, Jennifer M. Ahlstrom, Jay R. Hydren

Blood (2022) 140 (Supplement 1): 10940–10941.

https://doi.org/10.1182/blood-2022-171031

Published: 2022

Journal Articles

Clinician and Patient Perspectives on Treatment Decision-Making in Multiple Myeloma: A Qualitative Survey

Nina Shah, Elizabeth S. Mearns, Sean Carey, Emily Mulvihill, Sheri A. McClerklin, Karen Thomson, Jennifer M. Ahlstrom, Allicia Girvan, R. Frank Cornell, Michael Nixon

Blood (2022) 140 (Supplement 1): 12534–12536.

https://doi.org/10.1182/blood-2022-158520

Published: 2022

Journal Articles

A Retrospective Comparison of the Side Effect Prevalence and Severity of Multiple Myeloma Triplet Vs Quadruplet Induction Therapy

Nathan W. Sweeney, Emily W. Ballard, Eduardo Franco Hernandez, Andrea Isabel Robles Espinoza, Andrea Jimena Cuevas Vicencio, Patricia Alejandra Flores Pérez, Thomas H. Molina, Jennifer M. Ahlstrom, Jay R. Hydren

Blood (2022) 140 (Supplement 1): 7178–7179.

https://doi.org/10.1182/blood-2022-170392

Published: 2022

Journal Articles

What Are the Top Myeloma Patient Concerns at and Since Diagnosis?

Jennifer M. Ahlstrom, Nathan W. Sweeney, David F. Barton, Jorge Arturo Hurtado Hurtado Martinez, Jay R. Hydren

Blood (2022) 140 (Supplement 1): 13105.

https://doi.org/10.1182/blood-2022-170557

Published: 2022

Journal Articles

Utilizing HealthTree ® Cure Hub's Real-World Data to Assess Treatment Management of Patients with Multiple Myeloma during the COVID-19 Pandemic

Nathan W. Sweeney, Jennifer M. Ahlstrom

Blood (2021) 138 (Supplement 1): 5026.

https://doi.org/10.1182/blood-2021-150890

Published: 2021

Journal Articles

Online Patient-Reported Platform Detects Trend of Increased COVID-19 Risk and Severity for Multiple Myeloma Patients on Active Lenalidomide-Based Therapy

Emily I. Liu, Nathan W. Sweeney, Jennifer M. Ahlstrom

Blood (2021) 138 (Supplement 1): 4022.

https://doi.org/10.1182/blood-2021-151638

Published: 2021

Journal Articles

Multiple Myeloma, Clinical Characteristics, and Increased COVID-19 Risk Using Real-World Data

Emily I. Liu, Nathan W. Sweeney, Jennifer M. Ahlstrom

Blood (2021) 138 (Supplement 1): 3778.

https://doi.org/10.1182/blood-2021-152056

Published: 2021

NARROW

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma

Multiple Myeloma Patient Perceptions of Minimal Residual Disease Testing

Age-Based Comparison of Stem Cell Transplantation during the First Line of Therapy for Multiple Myeloma Patients

Dietary Patterns Among Individuals with Plasma Cell Disorders Compared to the General US Population

Age-Based Comparison of Dara-Rvd, Krd and Rvd Induction Therapies during the First Line of Therapy for Multiple Myeloma Patients

Unraveling the Dynamics of Protein Secretion in Multiple Myeloma: A Comparative Study of Non-Secretory Patterns and Disease Evolution

The Relationship between Therapeutic Pressure and Multiple Myeloma Risk Stratification: A 5 Year Real-World-Data Analysis

Understanding Patient Perspective, Challenges, Behavioral Patterns, and Preferences Towards Participation in Multiple Myeloma Clinical Trials: A Prospective Study

Microbial Changes in Response to a Plant-Based Diet and/or Supplements in SMM Patients: A National Multi-Arm Randomized Prospective Telehealth Study Via Healthtree: The Nutrition Prevention (NUTRIVENTION-2) Study

Physical Activity in Patients with Monoclonal Gammopathies - a Healthtree Cure Hub Study

The Top Concerns at and Since Diagnosis: Standard v. High Risk Myeloma Patients

Clinician and Patient Perspectives on Treatment Decision-Making in Multiple Myeloma: A Qualitative Survey

A Retrospective Comparison of the Side Effect Prevalence and Severity of Multiple Myeloma Triplet Vs Quadruplet Induction Therapy

What Are the Top Myeloma Patient Concerns at and Since Diagnosis?

Utilizing HealthTree ® Cure Hub's Real-World Data to Assess Treatment Management of Patients with Multiple Myeloma during the COVID-19 Pandemic

Online Patient-Reported Platform Detects Trend of Increased COVID-19 Risk and Severity for Multiple Myeloma Patients on Active Lenalidomide-Based Therapy

Multiple Myeloma, Clinical Characteristics, and Increased COVID-19 Risk Using Real-World Data

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only